Related Experiment Video
Updated: May 29, 2026
08:52
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
Customizing systemic therapy in patients with advanced non-small cell lung cancer
A M Sadowska1, V Nowé, A Janssens
1Dept of Respiratory Medicine, University Hospital Antwerp, Wilrijkstraat 10, 2650 Antwerp, Belgium.
Therapeutic Advances in Medical Oncology
|September 10, 2011
Summary
Personalized lung cancer therapy, considering patient genetics, tumor histology, and biomarkers, is crucial for improving treatment effectiveness beyond standard chemotherapy. This approach aims to tailor treatments for better outcomes in non-small cell lung cancer.
Area of Science:
- Oncology
- Genetics
- Personalized Medicine
Background:
- Lung cancer is a leading global cause of cancer mortality.
- Standard chemotherapy offers modest survival benefits and improved quality of life.
- Current treatment selection relies on general prognostic factors, leading to variable patient responses.
Purpose of the Study:
- To review personalized therapy strategies for non-small cell lung cancer.
- To explore tailoring treatments based on individual patient profiles.
- To highlight the role of genetic profiles, tumor histology, and biomarkers in customized therapy.
Main Methods:
- Review of current literature on personalized lung cancer treatment.
- Analysis of patient characteristics, tumor histology, and biomarkers.
- Focus on tailoring therapeutic regimens for non-small cell lung cancer.
Main Results:
- Personalized therapy holds potential to reduce response variability in lung cancer patients.
- Integrating genetic profiles can optimize medication efficacy.
- Tumor-specific factors are key to developing customized treatment plans.
Conclusions:
- Personalized therapy is essential for advancing non-small cell lung cancer treatment.
- Tailoring treatment to genetic makeup and tumor characteristics can improve patient outcomes.
- Further research into customized therapeutic approaches is warranted.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...